Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

NCT01949090 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Investigational H7N1 vaccine GSK2789869A
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline